Dr Amritha Nair

Industry Partnerships and Commercialisation Senior Executive, Faculty of Medicine

Dr Amritha Nair is an Industry Partnerships and Commercialisation Senior Executive in the Faculty of Medicine at Imperial College London. Amritha works across the entire innovation lifecycle from assessment, protection, and management of Intellectual property; marketing of technologies primed for commercialisation and supporting commercialisation via licensing or spinouts. Amritha also supports researchers in their bids for access to translational funding. Amritha manages an extensive IP portfolio, mainly focussed on therapeutics and diagnostics.

Prior roles include innovation consulting for small and medium enterprises and handling the drug development and start-up activities for a private equity backed life science development group in Houston, USA.

Amritha has a PhD in Molecular and Human Genetics from Baylor College of Medicine, Houston, USA and a MSc in Human Genetics from Sri Ramachandra University, Chennai, India.

Amritha's portfolio

Methods to scale production of hPSC-derived endothelial cells

Methods to scale production of hPSC-derived endothelial cells

A new 3D-culture methodology using stirred-tank bioreactors as a scalable platform for the production of hPSC-derived endothelial cells Find out more

Two distinct late stage preclinical lead series of highly specific inhibitors of MAP4K4

Two distinct late stage preclinical lead series of highly specific inhibitors of MAP4K4

A late-stage, pre-clinically validated inhibitor of MAP4K4 for a range of indications including anthracycline cardiotoxicity Find out more

Dual DNA-PK/AKT inhibition for the treatment of platinum-resistant cancer

Dual DNA-PK/AKT inhibition for the treatment of platinum-resistant cancer

Novel compounds with dual DNA-PK/AKT inhibitor activity for the treatment of platinum-resistant cancers. Find out more

SIMPLE: Single Incision Micro Ports for Laparoscopic Endo-surgery

SIMPLE: Single Incision Micro Ports for Laparoscopic Endo-surgery

A next generation surgical robotics platform for ultra-minimally invasive surgery via a single port, offering bimanual haptic control and enabling autonomous surgical tasks. Find out more

Sign up for updates

Sign up for monthly technology alerts via email, and find other ways to connect with us.

Loading...